tirzepatide for kidney disease (Zepbound) showed improved function in obese patients with both chronic kidney and #heartfailure with preserved ejection fraction, highlighting its potential to address this high-risk patient population. Read more: https Kidney Parameters with Tirzepatide in

What safety screenings should my GLP-1 provider conduct before prescribing

Slow Your Dose Escalation: The Two-Week Holding Strategy If nausea is severe, ask your PlexusDx provider about extending your dosing interval

The GLP-1 revolution is not just about a new class of drugs

Alternative treatment options should be discussed where appropriate, and patients should feel empowered to make informed choices about their care

Bezpieczestwo i skutki uboczne co warto wiedzie

5 Glucagon-Like Peptide-1 Receptor Agonist Medications Medications for diabetes including semaglutide (a long-acting glucagon-like peptide-1 receptor agonist (GLP-1)), liraglutide (a GLP-1 receptor agonist), and tirzepatide (a glucose-dependent insulinotropic polypeptide (GIP) receptor and GLP-1 receptor agonist) are all of major interest for weight loss